Evidence map›Paper›PMID 18842620›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2009

Roles of coactivator proteins in dioxin induction of CYP1A1 and CYP1B1 in human breast cancer cells.

Robert T Taylor, Feng Wang, Erin L Hsu, Oliver Hankinson

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Epigenetic Regulations of AhR in the Aspect of Immunomodulation.International journal of molecular sciences · 2020
    Review
  9. Review
  10. TCDD Toxicity Mediated by Epigenetic Mechanisms.International journal of molecular sciences · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Potential role of epigenetic mechanisms in the regulation of drug metabolism and transport.Drug metabolism and disposition: the biological fate of chemicals · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Robert T TaylorMolecular Toxicology Program, Department of Pathology and Laboratory Medicine, University of California, Los Angeles, California 90095, USA.
Feng Wang
Erin L Hsu
Oliver Hankinson
University of California, Los Angeles · USLaboratory of Molecular Genetics · PL

Funding

CARCINOGEN ACTIVATION AND SCREENING IN VARIANT CELLSR01CA028868 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HANKINSON, OLIVER NMN · 1985 to 2010
$3.6M
NCI NIH HHS R01 CA028868NCI NIH HHS R01CA28868
6 · The paper itself

Abstract

Cytochrome P450 (CYP) 1A1 and CYP1B1 are inducible by 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) in the human breast cancer cell line, MCF-7. Since CYP1A1 was inducible to a much greater degree than CYP1B1, we hypothesized that there may be differences in coactivator recruitment to the promoter and/or enhancer regions of these genes. Dioxin treatment leads to recruitment of the aryl hydrocarbon receptor to the enhancer regions but not to the proximal promoter regions of both the CYP1A1 and CYP1B1 genes. On the other hand, dioxin treatment facilitated recruitment of RNA polymerase II to the promoters but not the enhancer regions. Dioxin treatment also elicited recruitment of the transcriptional coactivators, steroid receptor coactivator 1 (SRC-1) and steroid receptor coactivator 2 (SRC-2) and p300, which possess intrinsic histone acetyltranferase activities, to both genes, whereas Brahma (BRM)/Switch 2-related gene 1 (BRG-1), a subunit of nucleosomal remodeling factors, was recruited more robustly to CYP1A1 relative to CYP1B1. Small inhibitory RNA-mediated knockdown of p300 and SRC-2 adversely affected dioxin induction of both genes, whereas knockdown of BRM/BRG-1 reduced CYP1A1 induction but had little, if any, effect on CYP1B1 induction. These results suggest that nucleosomal remodeling is less significant for dioxin-mediated induction of CYP1B1 than that of CYP1A1 and may be related to the more modest inducibility of the former. Interestingly, simultaneous knockdown of SRC-2 and BRM/BRG-1 had no greater effect on CYP1A1 induction than knockdown of each coactivator individually, while simultaneous knockdown of p300 and BRM/BRG-1 had a much greater effect than knockdown of each individual gene, suggesting that the recruitment of SRC-2 to CYP1A1 depends upon BRM/BRG-1, while the recruitments of p300 and BRM/BRG-1 are independent of each other. These observations provide novel insights into the functional roles of the endogenous coactivators in dioxin induction of the human CYP1A1 and CYP1B1 genes in their natural chromosomal configurations.

Indexed as

Aryl Hydrocarbon HydroxylasesBreast NeoplasmsCell Line, TumorCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1Cytochrome P-450 Enzyme SystemDNA HelicasesEnhancer Elements, GeneticFemaleGene Expression Regulation, NeoplasticGene Knockdown TechniquesHistone AcetyltransferasesHumansNuclear ProteinsNuclear Receptor Coactivator 1Nuclear Receptor Coactivator 2Aryl Hydrocarbon HydroxylasesCYP1B1 protein, humanCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1Cytochrome P-450 Enzyme SystemDNA HelicasesHistone AcetyltransferasesNCOA1 protein, humanNuclear ProteinsNuclear Receptor Coactivator 1Nuclear Receptor Coactivator 2p300-CBP Transcription FactorsPolychlorinated DibenzodioxinsReceptors, Aryl HydrocarbonRNA, Small InterferingSMARCA2 protein, humanSMARCA4 protein, humanTranscription Factors

Identifiers

PMID18842620
PMCPMC2638648
OpenAlexW2153237860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.